| Literature DB >> 33924254 |
Fábio A Abade Dos Santos1,2,3, Carina L Carvalho1, Maria C Peleteiro2, Francisco Parra3, Margarida D Duarte1,2.
Abstract
In late 2019, the first herpesvirus in the genus Lepus, named leporid gammaherpesvirus 5 (LeHV-5) was described. At the time, herpetic typical lesions were observed in hares infected by the myxoma virus, which is known to induce immunosuppression. Though the real impact of LeHV-5 is still poorly understood, since it affects reproduction, it poses an additional threat to the already fragile populations of Iberian hare, demanding prevalence investigations. In this article, we describe the first quantitative molecular method for LeHV-5 detection, using either Taqman or the EvaGreen systems. This method has excellent sensitivity and specificity, it is able to detect 2.1 copies of LeHV-5 DNA and was validated with an internal control targeting the 18S rRNA gene, allowing monitoring extraction and PCR amplification efficiencies.Entities:
Keywords: Iberian hare; Lepus granatensis; gammaherpesvirus; herpesvirus; leporid gammaherpesvirus 5; qPCR; reproduction
Year: 2021 PMID: 33924254 PMCID: PMC8074763 DOI: 10.3390/v13040715
Source DB: PubMed Journal: Viruses ISSN: 1999-4915 Impact factor: 5.048
Primers and probes designed for the qPCR systems.
|
| Primers (Name/Nucleotide Sequence (5′–3′)) | Probe (Name/Fluorophore/Sequence (5′–3′)/Quencher) |
|---|---|---|
|
| ||
|
|
Figure 1(A) Serial dilution from 2.1 × 108 to 2.1 copies per reaction. Black lines correspond to negative Scheme 2. 1 × 10−1 and 2.1 × 10−2 copies per reaction). (B) Standard curve from 2.1 × 108 to 2.1 copies per reaction.
Figure 2(A) Serial dilution from 2.1 × 108 to 2.1 x 100 copies per reaction. Black lines correspond to negative samples (2.1 × 10−1 and 2.1 × 10−2 copies per reaction). (B) Standard curve from 2.1 × 108 to 2.1 × 100 copies per reaction. (C) Melt point analysis for 36 reactions with 2.1 × 108 to 2.1 × 100 copies. (D) Melt curve analysis for 36 reactions with 2.1 × 108 to 2.1 × 100 copies.
Figure 3(A) Analysis of different primer concentrations for 18S DNA amplification. Fixed final concentration of the probe in all reactions (0.2 µM). Variable primer concentrations: 1 µM Fw primer, 1µM Rev primer (brown), 0.5 µM Fw primer, 1 µM Rv primer (dark green), 0.2 µM Fw primer, 1 µM Rev primer (light green), 1 µM Fw primer, 0.5 µM Rev primer (dark blue), 0.5 µM Fw primer, 0.5 µM Rv primer (red), 0.2 µM Fw primer, and 0.2 µM Rv primer (orange). (B) Serial dilution from 1.2 × 108 to 1.2 × 101 copies of p18S_ha per reaction. Black lines correspond to lack of amplification (1.2 × 100 and 1.2 × 10−1 copies per reaction). (C) Standard curve from 1.2 × 108 to 1.2 × 101 copies per reaction. (D) Amplification of 40 samples of DNA (liver and spleen) from Iberian hare field samples.
Cq values obtained with the 18S rDNA qPCR using European rabbit tissues submitted to different conservation/preservation conditions.
| Fresh | RT, 7 Days | 37 °C, 7 Days | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Diluent | Liver | Lung | Heart | Liver | Lung | Heart | Liver | Lung | Heart |
| PBS | 12.29 | 17.70 | 15.40 | 25.05 | 15.52 | 16.19 | 23.29 | 15.18 | 16.06 |
| PBS, AB, AM | 12.35 | 17.73 | 17.78 | 25.27 | 15.49 | 16.06 | 23.31 | 15.33 | 16.10 |
PBS (phosphate-buffered saline), AB—antibiotic, AM—antimycotic.
Summary of statistical analyses of the repeatability and reproducibility results for both qPCR systems for gB detection.
|
|
| |||||
|
|
| |||||
| Mean Cq | SD | %CV | Mean Cq | SD | %CV | |
| 2.1 × 108 | 10.73 | 0.181 | 1.69 | 10.32 | 0.185 | 1.79 |
| 2.1 × 107 | 13.44 | 0.093 | 0.69 | 13.55 | 0.101 | 0.75 |
| 2.1 × 106 | 16.31 | 0.061 | 0.37 | 16.10 | 0.070 | 0.43 |
| 2.1 × 105 | 20.03 | 0.086 | 0.43 | 19.86 | 0.084 | 0.42 |
| 2.1 × 104 | 23.47 | 0.114 | 0.49 | 22.85 | 0.104 | 0.46 |
| 2.1 × 103 | 27.31 | 0.080 | 0.29 | 27.44 | 0.082 | 0.30 |
| 2.1 × 102 | 30.45 | 0.222 | 0.73 | 30.11 | 0.256 | 0.85 |
| 2.1 × 101 | 34.07 | 0.159 | 0.47 | 34.05 | 0.175 | 0.51 |
| 2.1 × 100 | 36.36 | 0.897 | 2.47 | 37.13 | 0.904 | 2.43 |
|
| ||||||
|
|
|
| ||||
| Mean Cq | SD | %CV | Mean Cq | SD | %CV | |
| 2.1 × 108 | 10.19 | 0.076 | 0.75 | 10.67 | 0.090 | 0.84 |
| 2.1 × 107 | 13.31 | 0.074 | 0.56 | 13.80 | 0.114 | 0.83 |
| 2.1 × 106 | 17.18 | 0.073 | 0.42 | 16.89 | 0.094 | 0.56 |
| 2.1 × 105 | 20.70 | 0.188 | 0.91 | 20.14 | 0.250 | 1.24 |
| 2.1 × 104 | 24.29 | 0.269 | 1.11 | 23.98 | 0.314 | 1.31 |
| 2.1 × 103 | 27.91 | 0.044 | 0.16 | 27.50 | 0.098 | 0.36 |
| 2.1 × 102 | 31.30 | 0.248 | 0.79 | 31.05 | 0.322 | 1.04 |
| 2.1 × 101 | 34.89 | 0.177 | 0.51 | 34.60 | 0.198 | 0.57 |
| 2.1 × 100 | 37.63 | 0.491 | 1.30 | 37.40 | 0.503 | 1.34 |
CV—coefficient of variation.
Comparative final diagnosis between Nested PCR [11] and Taqman rt-qPCR system.
| Sample Code | Nested PCR * | Real Time (Cq) | Estimated Copies/mg Tissue * | |
|---|---|---|---|---|
| Amplification | Sequencing Analysis | |||
|
| N | - | NA | NA |
|
| P | LeHV-5 | 20.23 | 7.43 × 106 |
|
| N | - | NA | NA |
|
| P | LeHV-5 | 22.94 | 1.14 × 106 |
|
| P | LeHV-5 | 24.24 | 4.61 × 105 |
|
| N | - | NA | NA |
|
| N | - | NA | NA |
|
| N | - | NA | NA |
|
| N | - | NA | NA |
|
| P | LeHV-5 | 24.93 | 2.86 × 105 |
|
| P | LeHV-5 | 23.87 | 5.96 × 105 |
|
| P | LeHV-5 | 22.32 | 1.75 × 106 |
|
| P | LeHV-5 | 25.62 | 1.77 × 105 |
|
| P | LeHV-5 | 23.62 | 7.09 × 105 |
|
| N | - | NA | NA |
|
| N | - | NA | NA |
|
| N | - | NA | NA |
|
| N | - | NA | NA |
|
| N | - | NA | NA |
|
| N | - | NA | NA |
|
| N | - | NA | NA |
|
| D | unspecific | NA | NA |
|
| D | unspecific | NA | NA |
|
| D | unspecific | NA | NA |
|
| D | unspecific | NA | NA |
|
| N | - | NA | NA |
|
| P | LeHV-5 | 21.06 | 4.18 × 106 |
|
| P | LeHV-5 | 21.44 | 3.21 × 106 |
|
| D | LeHV-5 | 26.10 | 1.27 × 105 |
|
| D | unspecific | NA | NA |
|
| D | unspecific | NA | NA |
|
| D | unspecific | NA | NA |
|
| D | unspecific | NA | NA |
|
| D | unspecific | NA | NA |
|
| P | LeHV-5 | 25.08 | 2.58 × 105 |
|
| P | LeHV-5 | 26.45 | 9.97 × 104 |
|
| P | LeHV-5 | 25.02 | 2.69 × 105 |
|
| P | LeHV-5 | 14.27 | 4.63 × 108 |
|
| D | unspecific | NA | NA |
|
| P | LeHV-5 | 25.19 | 2.39 × 105 |
|
| P | LeHV-5 | 23.65 | 6.94 × 105 |
|
| P | LeHV-5 | 25.71 | 1.67 × 105 |
|
| D | herpesvirus | 28.36 | 2.65 × 104 |
|
| P | LeHV-5 | 22.57 | 1.47 × 106 |
|
| P | LeHV-5 | 26.59 | 9.05× 104 |
P—positive, N—negative, D—doubtful. NA (no amplification). * Estimative using the standard curve of Taqman system.
Figure 4(A) Amplification of LeHV-5 gB gene in singleplex and duplex also for 18S rRNA gene (CY5 channel, purple curves). Red lines correspond to LeHV-5 amplification in singleplex reactions and green in duplex reactions. Horizontal black lines correspond to samples lacking amplification (2.1 × 10−1 and 2.1 × 10−2 copies per reaction) (B) Amplification of LeHV-5 (red curves) in duplex with the 18S rRNA gene (CY5 channel, purple curves), using field samples.